Cannon Global Investment Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-35,000	Closed	-$111K	–	84
2025 Q1	$111K	Buy	+35,000	New	+$111K	0.2%	66